These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 37335659

  • 1. Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
    Huang KH, Lin HC, Lin CD, Wu PC.
    Medicine (Baltimore); 2023 Jun 09; 102(23):e33889. PubMed ID: 37335659
    [Abstract] [Full Text] [Related]

  • 2. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS, Meyerhoff WE, Cohen SB.
    Semin Arthritis Rheum; 2004 Oct 09; 34(2):544-8. PubMed ID: 15505770
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive therapy for autoimmune inner ear disease.
    Buniel MC, Geelan-Hansen K, Weber PC, Tuohy VK.
    Immunotherapy; 2009 May 09; 1(3):425-34. PubMed ID: 19885385
    [Abstract] [Full Text] [Related]

  • 4. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE.
    JAMA; 2003 Oct 08; 290(14):1875-83. PubMed ID: 14532316
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
    Lasak JM, Sataloff RT, Hawkshaw M, Carey TE, Lyons KM, Spiegel JR.
    Ear Nose Throat J; 2001 Nov 08; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
    [Abstract] [Full Text] [Related]

  • 6. Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease.
    Vambutas A, Lesser M, Mullooly V, Pathak S, Zahtz G, Rosen L, Goldofsky E.
    J Clin Invest; 2014 Sep 08; 124(9):4115-22. PubMed ID: 25133431
    [Abstract] [Full Text] [Related]

  • 7. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F, Staecker H, Keithley E, Lefebvre PP.
    Audiol Neurootol; 2006 Sep 08; 11(6):357-65. PubMed ID: 16988499
    [Abstract] [Full Text] [Related]

  • 8. Corticosteroid response and supporting cell antibody in autoimmune hearing loss.
    Zeitoun H, Beckman JG, Arts HA, Lansford CD, Lee DS, El-Kashlan HK, Telian SA, Denny DE, Ramakrishnan A, Nair TS, Disher MJ, Sataloff RT, Fisher SG, Carey TE.
    Arch Otolaryngol Head Neck Surg; 2005 Aug 08; 131(8):665-72. PubMed ID: 16103296
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune inner ear disease.
    Ruckenstein MJ.
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct 08; 12(5):426-30. PubMed ID: 15377956
    [Abstract] [Full Text] [Related]

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.
    Acta Dermatovenerol Croat; 2016 Apr 08; 24(1):83-5. PubMed ID: 27149138
    [Abstract] [Full Text] [Related]

  • 11. IL-1β inhibition in autoimmune inner ear disease: can you hear me now?
    Rauch SD.
    J Clin Invest; 2014 Sep 08; 124(9):3685-7. PubMed ID: 25133418
    [Abstract] [Full Text] [Related]

  • 12. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.
    García-Berrocal JR, Ibáñez A, Rodríguez A, González-García JA, Verdaguer JM, Trinidad A, Ramírez-Camacho R.
    Eur Arch Otorhinolaryngol; 2006 Nov 08; 263(11):977-82. PubMed ID: 16802138
    [Abstract] [Full Text] [Related]

  • 13. Immune-mediated inner ear disease and parvovirus B19.
    Cotter CS, Singleton GT, Corman LC.
    Laryngoscope; 1994 Oct 08; 104(10):1235-9. PubMed ID: 7934594
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease.
    Saraçaydin A, Katircioglu S, Katircioglu S, Karatay MC.
    J Int Med Res; 1993 Oct 08; 21(4):192-6. PubMed ID: 8112477
    [Abstract] [Full Text] [Related]

  • 15. Cochlin in autoimmune inner ear disease: is the search for an inner ear autoantigen over?
    Baruah P.
    Auris Nasus Larynx; 2014 Dec 08; 41(6):499-501. PubMed ID: 25199741
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M, Brassington R, Gunn AA, van Doorn PA, Hughes RA.
    Cochrane Database Syst Rev; 2017 May 08; 5(5):CD003280. PubMed ID: 28481421
    [Abstract] [Full Text] [Related]

  • 17. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I, Jobanputra P, Proops DW.
    J Laryngol Otol; 2006 Dec 08; 120(12):1064-6. PubMed ID: 17040588
    [Abstract] [Full Text] [Related]

  • 18. Infliximab for autoimmune inner ear disease: case report and literature review.
    Heywood RL, Hadavi S, Donnelly S, Patel N.
    J Laryngol Otol; 2013 Nov 08; 127(11):1145-7. PubMed ID: 24125068
    [Abstract] [Full Text] [Related]

  • 19. Demystifying autoimmune inner ear disease.
    Das S, Bakshi SS, Seepana R.
    Eur Arch Otorhinolaryngol; 2019 Dec 08; 276(12):3267-3274. PubMed ID: 31605190
    [Abstract] [Full Text] [Related]

  • 20. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
    Cohen S, Shoup A, Weisman MH, Harris J.
    Otol Neurotol; 2005 Sep 08; 26(5):903-7. PubMed ID: 16151336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.